The hope for many companies developing drugs for rare diseases is this: the significant unmet need, given a dearth of treatment options, will drive demand and thus product uptake. Unfortunately, […]
Finding Patients With Rare Diseases: Two Truths And A Lie Read More »
The Twin High-Leverage Points of Identification and Activation To successfully address unmet medical needs in rare disease, we must first identify health care providers (HCPs) with a high likelihood of
Leverage AI for Precision in Rare Disease Diagnosis Read More »
The rare disease in question suffers from significant underdiagnosis and underdocumentation due to the absence of a specific ICD-10 code and the heterogeneous nature of its phenotype. Despite the necessity
Rare Disease Patient Identification Project Case Study Read More »